SJP-0132 Phase 3 -Multicenter, Open-label, Long-term Study in Patients with Dry Eye Disease-
SJP-0132 Phase 3 - Multicenter, Randomized, Double-Masked, Placebo Controlled, Parallel-Group Study in Patients with Dry Eye Disease -
SJP-0132 Phase 2 - A Multicenter, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group Study in Participants with Dry Eye Disease -
100 项与 SJP-0132 相关的专利(医药)